![](https://ml-eu.globenewswire.com/media/64e19e59-bc37-4c58-b2cf-9eaaab9d555e/small/inbrain-pharma-logo-png.png)
InBrain Pharma announces the publication of an article on the pharmacokinetic and pharmacodynamic limitations of L-DOPA ...
InBrain Pharma announces the publication of an article on the pharmacokinetic and pharmacodynamic limitations of L-DOPA in the management of Parkinson's disease in the Journal of Parkinson's Disease Lille, September 11th, 2024– InBrain …